PropertyValue
?:abstract
  • BACKGROUND Vascular endothelial growth factor (VEGF)-induced angiogenesis is a critical compensatory response to microvascular rarefaction in the diabetic retina that contributes to proliferative diabetic retinopathy (PDR). In this study, we sought to determine the role of specific microRNA (miRs) associated with VEGF in patients with PDR pathology. METHODS RNA sequencing was employed to detect differentially circulating microRNA (miR) associated with VEGF in DM (Diabetes mellitus), NPDR (non-proliferative diabetic retinopathy) and PDR patients. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to measure the concentration of miR-15b in the serum of DM patients (n=115), NPDR (n=47) or PDR (n=76). The effects of miR-15b on DR and regulation of VEGF and endothelial cell function were also characterized. RESULTS We demonstrated that circulating miR-15b was directly associated with VEGF compared to other miRs in PDR patients. We found a significant inverse relationship between low levels of miR-15b and high levels of VEGF in patients with PDR when compared to the DM or NPDR groups. We found that miR-15b regulates the expression of VEGF by targeting the 3\'-UTR regions to inhibit its transcription. Similarly, overexpression of miR-15b suppressed vascular abnormalities in vivo in diabetic GK rats, inhibiting endothelial tube formation, and VEGF expression. CONCLUSION In conclusion, circulating miR-15b is associated with PDR and may be targeted to regulate VEGF expression and angiogenesis.
is ?:annotates of
?:creator
?:doi
  • 10.1210/clinem/dgaa538
?:doi
?:journal
  • The_Journal_of_clinical_endocrinology_and_metabolism
?:license
  • unk
?:pmid
?:pmid
  • 32797181
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • Medline
?:title
  • MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy.
?:type
?:year
  • 2020-08-14

Metadata

Anon_0  
expand all